Related Experiment Video
Updated: May 26, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Robot-assisted laparoscopic retroperitoneal lymph node dissection in an adolescent population.
Nicholas G Cost1, Daniel G DaJusta, Candace F Granberg
1Division of Pediatric Urology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA. nicholas.cost@sbcglobal.net
Journal of Endourology
|December 7, 2011
Summary
Robot-assisted laparoscopic retroperitoneal lymph node dissection (RPLND) is safe and effective for adolescents with paratesticular rhabdomyosarcoma and testicular germ-cell tumors. This minimally invasive approach offers good outcomes with low morbidity.
Area of Science:
- Urology
- Pediatric Oncology
- Surgical Technology
Background:
- Laparoscopic retroperitoneal lymph node dissection (RPLND) is established for pediatric and adolescent patients with paratesticular rhabdomyosarcoma (PT-RMS) and testicular germ-cell tumors (T-GCT).
- Robot-assisted laparoscopy adoption is increasing across surgical fields, yet its application in RPLND remains minimally reported.
Observation:
- This study presents two adolescent cases undergoing robot-assisted laparoscopic RPLND (R-RPLND).
- One case involved PT-RMS, and the other involved T-GCT.
Findings:
- Both adolescent patients treated with R-RPLND experienced positive outcomes.
- The R-RPLND procedure demonstrated low morbidity in both cases.
Implications:
- Robot-assisted laparoscopic RPLND is a viable and effective minimally invasive option for select pediatric and adolescent patients with PT-RMS and T-GCT.
- This technique may expand the application of robotic surgery in pediatric urologic oncology.
- Further research is warranted to establish the long-term efficacy and broader applicability of R-RPLND.